Searched for
ENTOD PHARMACEUTICALS
Budget 2026 wish-list: Pharma sector seeks API self-reliance, export incentives to strengthen India’s ‘Pharmacy of the World’ tagAhead of the Union Budget 2026, pharma players push for API self-reliance and export competitiveness.- Trump slaps 100% tariff on branded drugs; Indian pharma companies see limited near-term impactPlayers like Sun Pharma, Dr. Reddy’s and Cipla, who derive 30-50% of their revenues from the US market, brace for potential disruption to t...
- Trump’s tariff rhetoric sets backdrop for India’s pharma confidence at iPHEX 2025Alongside the exhibition, the Global Regulatory Conclave, held with CDSCO and Pharmexcil, spotlights reliance practices, pharmacopoeia conv...
- Trump tariffs to push up US drug prices, won’t change India’s pharma growth playbook: PharmexcilIndia’s pharma strategy is long-term and not reactive to tariffs, said Pharmexcil.
- Pharma lobby flags 'cumbersome' export rule, seeks changePharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export...
- Trump’s tariffs shake global pharma—India at the crossroads of crisis and opportunityWith Trump’s tariffs poised to disrupt global pharma trade, industry stakeholders see opportunities for India, provided it takes strategic ...
- India’s Growing Prowess as a Global Leader in Healthcare Innovation
- Suspended eye drops not intended to replace glasses, says Entod CEOMumbai-based Entod Pharmaceuticals clarified that its eye drop PresVu is not intended to replace reading glasses for presbyopia. This follo...
- Govt suspends license of PresVu wonder eye drops which claimed to replace reading glassesThe Drug Controller General of India has suspended the licence for PresVu, an eye drop by Entod Pharmaceuticals, due to unauthorised promot...
- DCGI suspends nod to Entod's new eye drops over unapproved 'claims'India's drug regulator has suspended Entod Pharmaceuticals' permission to manufacture and sell PresVu Eye Drops. The company did not obtain...
- DCGI suspends permission to Entod pharma's eye drop, company to challenge order in courtThe DCGI has suspended Entod Pharmaceuticals' permission to manufacture and sell eye drops claimed to reduce dependency on reading glasses ...
- Presvu Eye Drops: Govt okays eye drops that can improve vision in 15 minutes, sales start next monthEntod pharmaceuticals Presvu Eye Drops: The Drug Controller General of India has approved PresVu eye drops, developed by Entod Pharmaceutic...
- Budget 2024: More funds and focus on R&D can solve many problems of pharma sector, say stakeholdersThe upcoming budget should focus on streamlining regulatory compliance and help the domestic pharma sector to boost their manufacturing cap...
- Pharma industry’s costly transition to sustainability can be made lucrativeRise in production costs have discouraged the pharma sector move towards decarbonisation. But the long-term advantages of going green shoul...
- Decoded: How India makes affordable drugs for developed world, but ‘deadly’ medicines for developing countriesIndia is called the 'pharmacy of the world' because it makes and exports drugs worth millions of dollars to many countries. But recent inci...
- Tarnished by cough syrup deaths, India’s pharma industry tries to look beyond the stuporThe reputation of the Indian pharma sector has seen some setbacks lately but the industry is strong enough to make a comeback.
- Budget 2023: 'Pharmacy of the world' has a Chinese Achillean heelGiven how crucial the pharmaceutical industry is to the country’s economy, its reliance on China for raw materials is particularly alarming...
- Why the health of India’s $50-billion pharma industry depends on ChinaThe country’s dependence on imports of raw materials to make medicines is at a disconcerting level now, especially with the government focu...
- QR codes on medicines: Experts underline challenges for industryThe National Pharmaceutical Pricing Authority (NPPA) has identified the 300 most used drugs for QR codes.
- Higher Budget allocation for healthcare a welcome move for the sector, says IndustryFinance Minister Nirmala Sitharaman on Monday proposed Rs 2,23,846 crore budget outlay for health and wellbeing for 2021-22, compared to Rs...
Load More
